Medtech Insight/Windhover Information's "Medical Device Investor Day" Symposium to...

Medtech Insight/Windhover Information's "Medical Device Investor Day" Symposium to Feature Presentations by 3M, B. Braun, BD, Boston Scientific, Covidien, Ethicon/J&J, Medtronic and Stryker, Among Others

October 22, 2008, Boston, MA
IRVINE, Calif.--(Business Wire)--
Medtech Insight, a division of FDC/Windhover and Reed Elsevier and
a leading provider of business information for the medical device
industry, has announced that its first-of-its-kind "Medical Device
Investor Day" symposium on October 22nd in Boston, MA, will feature
illuminating presentations by senior executives from approximately 15
of the most influential large companies in the device space, with 8
presenters confirmed to date. The all-day Investor Day event is being
held at the Westin Copley Place in Boston, immediately prior to its
annual "Investment In Innovation (In3) East" event. The symposium
represents an extraordinary opportunity for attendees to learn
first-hand what the powerhouses of the device industry are thinking,
doing, and planning in terms of investment, as well as partner and
network with our audience of key decision-makers from the medical
device and healthcare investment industries.

At Investor Day, senior executives from a carefully selected group
of the most influential device companies in the industry will speak
candidly on what interests them most in medical device technologies,
therapeutic areas, products, and geographic markets. They will also
inform our audience about partnering opportunities, how companies can
maximize their visibility in front of large company investors, and
what role M&A plays at their companies. The eight confirmed presenters
for Investor Day to date include Susan Paquette, Technology Assessment
Director at 3M; Paul O'Connell, Vice President, Vascular
Interventional Products Group at B. Braun Medical; Becton Dickinson
(BD), Jim Gilbert, Executive Vice President, Strategy and Business
Development at Boston Scientific; Dennis Crowley, Director Business
Development at Covidien; M. E. Helms, Director, WW New Business
Development at Johnson & Johnson Wound Management, a division of
Ethicon; Shawn McCormick, Director, Corporate Development at
Medtronic; and a key executive from Stryker, among others being added
regularly to the program.

David Cassak, Managing Partner at Windhover Information, kicks off
this exciting day with an opening keynote address on the state of
larger medical technology company M&A and deal trends. He will be
discussing which investment models for larger companies are working,
how larger companies are sustaining growth and what the current and
future appetite is for M&A.

Investor Day attendees will walk away with practical, real-life
lessons and advice from some of the most experienced dealmakers in the
worldwide medical technology marketplace. The registration rate for
Medical Device Investor Day only is $795, or this is discounted to
$495 when registering for In3 East at the same time. Full event
details are available on the event website, at
www.windhover.com/investorday.

Medical Device Investor Day is immediately followed by the
company's annual "Investment In Innovation (In3) East" conference,
taking place the evening of October 22 through the afternoon of
October 24, also at The Westin Copley Place in Boston, MA. More than
30 early- to late-stage device companies seeking investment and/or
strategic partnership are confirmed to date to present, with more than
50 companies presenting on the In3 East stage in all (most for the
first time). It is a do-not-miss event for those looking to partner,
invest and network with the most promising young medical technology
companies on course to impact the worldwide med device market, and
complements the large company investment and partnering focus of the
"Medical Device Investor Day" symposium. Full event details are
available at www.windhover.com/in3east08.

Medtech Insight and its parent company, FDC/Windhover and Reed
Elsevier, have established a reputation as holding the premier forums
worldwide for discerning senior executives in the medical device,
diagnostics, biotech, and pharmaceutical business development and
investment communities to meet and screen promising early-stage life
sciences companies in need of funding, acquisition and/or strategic
partnership, and to network with key decision makers in the industry.
Over 1400 emerging medical technology company presenters and over 7500
attendees have participated at In3 events over the past 7 years.

Medtech Insight and FDC/Windhover will also hold their "Investment
In Innovation (In3) West" conference at The Palazzo in Las Vegas, NV,
March 2-4, 2009, followed by "Investment In Innovation (In3) Europe"
at the Marriott Rive Gauche Hotel in Paris, April 29-30.

Medtech Insight
A division of FDC/Windhover and Reed Elsevier
Kristy Grimes, 480-985-9512
or 888-202-5939 toll-free in the U.S.
kristy@medtechinsight.com
Kayleen Kell, 949-453-0071, ext. 313
or 888-290-2225 toll-free in the U.S.
kayleen@medtechinsight.com
www.medtechinsight.com

Copyright Business Wire 2008